![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
*
Veterinary Medical Research Institute, Nutritional Immunology, College of Veterinary Medicine, Ames, IA 50011;
Department of Animal Science, Iowa State University, Ames, IA 50010; and
U.S. Department of Agriculture–Animal and Plant Health Inspection Service, Ames, IA 50010
3To whom correspondence should be addressed. E-mail: bassy{at}iastate.edu.
Excessive intake of saturated fatty acids and/or linoleic acid favors the induction of an array of lipid mediators and cytokines enhancing inflammatory responses. Conversely, dietary supplementation with (n-3) fatty acids or vitamin D ameliorates inflammation and autoimmune diseases. Although it was well accepted that conjugated linoleic acid (CLA) prevented diseases with a common inflammatory pathogenesis (i.e., cancer and atherosclerosis), no studies were available on the roles of CLA in mucosal inflammation. The present study was designed to investigate the anti-inflammatory actions and molecular mechanisms underlying the regulation of colonic health by CLA. We hypothesized that colonic inflammation can be ameliorated by dietary CLA supplementation. To test this hypothesis, inflammation of the colonic mucosa was triggered by challenging pigs fed either soybean oil–supplemented or CLA-supplemented diets with an enteric bacterial pathogen (i.e., Brachyspira hyodysenteriae). Immunoregulatory cytokines and peroxisome proliferator-activated receptor-
(PPAR-) mRNA expression were assayed in colonic lymph nodes and colon of pigs. Colonic mucosal lesions and lymphocyte subset distribution were evaluated by histology and immunohistochemistry. Supplementation of CLA in the diet before the induction of colitis decreased mucosal damage; maintained cytokine profiles (i.e., interferon- and interleukin-10) and lymphocyte subset distributions (i.e., CD4+ and CD8+), resembling those of noninfected pigs; enhanced colonic expression of PPAR-; and attenuated growth failure. Therefore, CLA fed preventively before the onset of enteric disease attenuated inflammatory lesion development and growth failure.
KEY WORDS: • lipid nutrition • colitis • conjugated linoleic acid • interferon- • PPAR- • growth suppression
This article has been cited by other articles:
|
|
 |
|
  D. E. Butz, G. Li, S. M. Huebner, and M. E. Cook A mechanistic approach to understanding conjugated linoleic acid's role in inflammation using murine models of rheumatoid arthritis Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R669 - R676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D Whigham, A. C Watras, and D. A Schoeller Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1203 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kohno, R. Suzuki, Y. Yasui, S. Miyamoto, K. Wakabayashi, and T. Tanaka Ursodeoxycholic Acid versus Sulfasalazine in Colitis-Related Colon Carcinogenesis in Mice Clin. Cancer Res., April 15, 2007; 13(8): 2519 - 2525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bassaganya-Riera, A. J Guri, A. M Noble, K. A Reynolds, J. King, C. M Wood, M. Ashby, D. Rai, and R. Hontecillas Arachidonic acid and docosahexaenoic acid enriched formulas modulate antigen-specific T cell responses to influenza virus in neonatal piglets Am. J. Clinical Nutrition, March 1, 2007; 85(3): 824 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Dubuquoy, C Rousseaux, X Thuru, L Peyrin-Biroulet, O Romano, P Chavatte, M Chamaillard, and P Desreumaux PPAR{gamma} as a new therapeutic target in inflammatory bowel diseases. Gut, September 1, 2006; 55(9): 1341 - 1349. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jonasson, M. Andersson, T. Rasback, A. Johannisson, and M. Jensen-Waern Immunological alterations during the clinical and recovery phases of experimental swine dysentery. J. Med. Microbiol., July 1, 2006; 55(Pt 7): 845 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Gaullier, J. Halse, K. Hoye, K. Kristiansen, H. Fagertun, H. Vik, and O. Gudmundsen Supplementation with Conjugated Linoleic Acid for 24 Months Is Well Tolerated by and Reduces Body Fat Mass in Healthy, Overweight Humans J. Nutr., April 1, 2005; 135(4): 778 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Changhua, Y. Jindong, L. Defa, Z. Lidan, Q. Shiyan, and X. Jianjun Conjugated Linoleic Acid Attenuates the Production and Gene Expression of Proinflammatory Cytokines in Weaned Pigs Challenged with Lipopolysaccharide J. Nutr., February 1, 2005; 135(2): 239 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Gaullier, J. Halse, K. Hoye, K. Kristiansen, H. Fagertun, H. Vik, and O. Gudmundsen Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1118 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J Field and P. D Schley Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1190S - 1198S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O'Shea, J. Bassaganya-Riera, and I. C. Mohede Immunomodulatory properties of conjugated linoleic acid Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1199S - 1206S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Dugan, J. L Aalhus, and J. K. Kramer Conjugated linoleic acid pork research Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1212S - 1216S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bassaganya-Riera, R. M. Pogranichniy, S. C. Jobgen, P. G. Halbur, K.-J. Yoon, M. O'Shea, I. Mohede, and R. Hontecillas Conjugated Linoleic Acid Ameliorates Viral Infectivity in a Pig Model of Virally Induced Immunosuppression J. Nutr., October 1, 2003; 133(10): 3204 - 3214. [Abstract] [Full Text] [PDF]
|
|
